/
NXTBF
$7.30+$2.20 (+43.14%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
Grey Market
OS
Price (6 mo)
Loading chart…
Change+$2.20
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue | $9.6M | $6.7M | $5.6M | $4.7M | $3.3M | $6.3M |
| Cost of revenue | $15.6M | $11.6M | $10.0M | $7.6M | $7.1M | $2.8M |
| Gross profit | −$6.0M | −$4.8M | −$4.4M | −$2.8M | −$3.8M | $85.4K |
| Gross margin | -62.0% | -71.3% | -77.9% | -59.6% | -114.7% | 1.4% |
| R&D | $10.3M | $4.2M | $622.9K | $562.4K | $885.9K | $366.5K |
| Operating income | −$18.6M | −$11.3M | −$7.9M | −$5.1M | −$6.6M | −$4.0M |
| EBITDA | −$16.7M | −$10.4M | −$5.7M | −$4.2M | −$5.7M | −$3.5M |
| Net income | −$18.9M | −$11.9M | −$6.8M | −$4.7M | −$6.5M | −$4.0M |
| Net margin | -197.1% | -176.2% | -120.5% | -99.6% | -195.0% | -63.2% |
| EPS (diluted) | -0.42 | -0.18 | -0.08 | -0.05 | -0.07 | -0.04 |
Annual figures · source: Financial Modeling Prep
Peer comparison
NEXT BIOMETRICS GROUP
NEXT BIOMETRICS GROUP
Held by traders on TradeandTell
No one on the platform currently holds NXTBF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NXTBF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-04-13 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded NXTBF yet.